{
	"name": "Sarcoma",
	"id": 3423,
	"graph": {
		"adjVertices": {
			"1": [
				{"2": "1"},
				{"4": "1"},
				{"5": "1"},
				{"6": "1"},
				{"7": "1"}
			],
			"7": [
				{"8": "1"},
				{"9": "1"}
			],
			"9": [
				{"10": "1"},
				{"11": "1"},
				{"12": "1"},
				{"13": "1"},
				{"14": "1"}
			]
		},
		"idToVertexMap": {
			"1": {
				"nameId": "1",
				"nomenclature": "sarcoma"
			},
			"2": {
				"nameId": "2",
				"nomenclature": "mesenchymal origin"
			},
			"4": {
				"nameId": "4",
				"nomenclature": "bone sarcoma"
			},
			"5": {
				"nameId": "5",
				"nomenclature": "soft tissue sarcoma"
			},
			"6": {
				"nameId": "6",
				"nomenclature": "survival rate: 60%-80%"
			},
			"7": {
				"nameId": "7",
				"nomenclature": "therapy"
			},
			"8": {
				"nameId": "8",
				"nomenclature": "surgical resection"
			},
			"9": {
				"nameId": "9",
				"nomenclature": "chemotherapy"
			},
			"10": {
				"nameId": "10",
				"nomenclature": "doxorubicin"
			},
			"11": {
				"nameId": "11",
				"nomenclature": "ifosfamide"
			},
			"12": {
				"nameId": "12",
				"nomenclature": "dacarbazine"
			},
			"13": {
				"nameId": "13",
				"nomenclature": "gemcitabine"
			},
			"14": {
				"nameId": "14",
				"nomenclature": "docetaxel"
			}
		},
		"idToEdgePropsMap": {
			"1": {
				"nameId": "1",
				"edgeWeight": 3.2
			}
		}
	}
}